Illingworth Research Group — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Illingworth Research Group is a private, revenue-generating service provider that addresses critical pain points in clinical trial execution: patient recruitment, diversity, and retention. Its core business model involves deploying mobile research nursing and patient concierge services to decentralize trials and support research sites. By reducing logistical and cost burdens for participants, the company aims to accelerate trial completion for its pharmaceutical and biotech clients. It represents a specialized player in the growing market for patient-focused clinical trial support services.

Drug DeliveryMedical Devices

Technology Platform

Integrated service platform for decentralized and hybrid clinical trials, comprising Mobile Research Nursing (in-home visits), Patient Concierge Services (logistical support to sites), and Clinical Trial Site Support.

Opportunities

The strong industry shift towards patient-centric and decentralized clinical trial models creates a significant tailwind for IRG's services.

Growing emphasis on improving participant diversity and retention presents a direct opportunity to demonstrate value to sponsors seeking more efficient and inclusive trials.

Risk Factors

Faces competition from large CROs and niche service providers.

Operational performance is tied to recruiting and managing a qualified, geographically dispersed network of research nurses.

Revenue dependency on a limited client base and sensitivity to biopharma R&D spending cycles.

Competitive Landscape

IRG competes in the fragmented clinical trial support services market. Competitors range from large, full-service global CROs (e.g., IQVIA, ICON, Parexel) with their own decentralized trial units to specialized mobile nursing companies and tech-focused virtual trial platforms. Differentiation is based on service quality, flexibility, and patient-centric focus.

More companies in United Kingdom →